04/26/2024 4:10 PM | Unicycive Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 4:11 PM | Unicycive Therapeutics (Filer)
| Form ARS | |
04/26/2024 4:12 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
04/17/2024 3:31 PM | Gupta Shalabh K. (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:31 PM | Gupta Pramod (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:32 PM | Jermasek Douglas (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:33 PM | Townsend John (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/28/2024 3:06 PM | Unicycive Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/20/2024 4:09 PM | Unicycive Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
02/14/2024 5:41 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 2:18 PM | ARMISTICE CAPITAL, LLC (Filed by) Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024 3:27 PM | Logos Global Management LP (Filed by) Unicycive Therapeutics (Subject)
| Form SC 13G | |
12/08/2023 3:36 PM | Unicycive Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/14/2023 3:20 PM | Unicycive Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023 10:12 AM | Unicycive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 3:05 PM | Unicycive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 3:30 PM | Aggarwal Gaurav (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 3:32 PM | Ryan John L (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 3:33 PM | Kenkare-Mitra Sara (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 3:34 PM | Laumas Sandeep (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 3:05 PM | Kenkare-Mitra Sara (Reporting) Unicycive Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/06/2023 8:16 AM | Unicycive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/30/2023 3:45 PM | Jermasek Douglas (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 3:46 PM | Townsend John (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 3:47 PM | Gupta Shalabh K. (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 3:47 PM | Gupta Pramod (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 8:19 PM | Unicycive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 4:12 PM | Unicycive Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
07/31/2023 3:15 PM | Unicycive Therapeutics (Filer) Unicycive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2023 5:05 AM | Unicycive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/14/2023 3:30 PM | Unicycive Therapeutics (Subject) Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
07/13/2023 7:42 PM | Aggarwal Gaurav (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 6:33 PM | Jermasek Douglas (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 6:01 PM | Gupta Pramod (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 5:10 PM | Gupta Shalabh K. (Reporting) Unicycive Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 6:49 PM | Unicycive Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/06/2023 4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Unicycive Therapeutics (Subject)
| Form SC 13G | |
07/06/2023 3:30 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Unicycive Therapeutics (Subject)
| Form SC 13G | |
06/26/2023 3:15 PM | Unicycive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 8:54 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
Guard Against the Coming Financial Upheaval (Ad) America’s Most Shocking Financial Story…
Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. |
05/23/2023 3:05 PM | Unicycive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |